Myriad Genetics | MYGN - Операционный доход





Операционный доход Изменить Дата
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 752M 125M 2026-06
Bio-Rad Laboratories USD 72.6M 38.5M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Danaher USD 1.13B 217M 2026-06
Illumina USD 260M 21M 2026-06
J&J USD 7.48B 860M 2026-06
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 459M 60M 2026-06
Quidel USD -15.3M 16.5M 2026-06
Repligen USD 21.13M 1.15M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Standard Biotools USD -9.42M 12.51M 2026-03
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Waters USD -86M 234M 2026-06